These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11765065)

  • 1. Biological factors influencing optimum fractionation in radiation therapy.
    Fowler JF
    Acta Oncol; 2001; 40(6):712-7. PubMed ID: 11765065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [For which tumor entities are effects of overall treatment time on the results of radiotherapy evident?].
    Stuschke M; Marnitz S; Wurm R; Budach V
    Strahlenther Onkol; 2000 Oct; 176(10):462-5. PubMed ID: 11068591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma.
    Fowler JF; Ritter MA
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):521-9. PubMed ID: 7751194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast neutron radiation therapy. Results of phase III randomized trials in head and neck, lung, and prostate cancers.
    Koh WJ; Griffin TW; Laramore GE; Stelzer KJ; Russell KJ
    Acta Oncol; 1994; 33(3):293-8. PubMed ID: 8018358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
    Kim H; Ahn YC; Park HC; Lim DH; Nam H
    J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of generalized time-dependent TCP model and the investigation of the effect of repopulation and weekend breaks in fractionated external beam therapy.
    Lee TK; Rosen II
    J Theor Biol; 2021 Mar; 512():110565. PubMed ID: 33346019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accelerated hyperfractionation radiation therapy combined with chemotherapy for non-small cell lung cancer complicated with superior vena cava syndrome].
    Ye M; Wang L; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):426-7. PubMed ID: 11810779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Split-course radiotherapy or treatment interruption].
    Feldmann HJ
    Strahlenther Onkol; 2000 Oct; 176(10):458-61. PubMed ID: 11068590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
    Ruggieri R
    Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
    Perez CA; Pajak TF; Rubin P; Simpson JR; Mohiuddin M; Brady LW; Perez-Tamayo R; Rotman M
    Cancer; 1987 Jun; 59(11):1874-81. PubMed ID: 3032394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
    Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07.
    Byhardt RW; Pajak TF; Emami B; Herskovic A; Doggett RS; Olsen LA
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):459-68. PubMed ID: 8390420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial.
    Fu XL; Jiang GL; Wang LJ; Qian H; Fu S; Yie M; Kong FM; Zhao S; He SQ; Liu TF
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):545-52. PubMed ID: 9336130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The time factor in oncological therapy].
    Baumann M; Herrmann T
    Strahlenther Onkol; 2000 Oct; 176(10):441-2. PubMed ID: 11068586
    [No Abstract]   [Full Text] [Related]  

  • 18. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fractionation schemes in radiotherapy.
    Stuschke M; Pöttgen C
    Front Radiat Ther Oncol; 2010; 42():150-156. PubMed ID: 19955801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.